Last week, I wrote about the risks of Amanita muscaria, a psychedelic mushroom that roughly 3.5 million American adults — about 1 in 100 — used in 2025, according to new data from Rand. That number is ...
First it was wine. Then it was weed. Now? Mushrooms. Microdosing psilocybin, the active compound in so-called “magic mushrooms,” is the latest mind-altering trend catching on with exhausted, ...
Could it be magic? A trip into the future of psychedelics with the father of microdosing - Dr James Fadiman is on a microdosing mission — and thinks you should try it too ...
Microdosing psychedelics, typically with psilocybin, the active compound in “magic mushrooms,” has become an increasingly popular approach for supporting mental health and well-being. But beyond the ...
Imagine you purchase a bag of gummies labeled nootropic — a term used to describe substances that claim to enhance mental ability and function, or “smart drugs.” However, within hours of consuming ...
For years, people from CEOs to novelists have taken tiny amounts of psychedelics to support well-being. New research shows ...
Psychedelics are catching on in the United States, but not always to find one's third eye or reach another plane of reality, ...
This trip might just be worth taking. New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive disorder. That’s noteworthy, since ...
Imagine you purchase a bag of gummies labeled nootropic – a term used to describe substances that claim to enhance mental ability and function, or "smart drugs." However, within hours of consuming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results